Gene Goldwasser died last week. He was 88, and he was my friend.
I wrote previously about a series of conversations I conducted with Gene and Rabbi A.J. Wolf a few years ago. I met Gene one spring day after calling to invite him to sit in on a class I was teaching to a small group of medical students about social issues in healthcare.
I’d read about him in a book called “The $800 Million Pill,” by Merrill Goozner. In the book, Goozner writes the story of Gene’s two-decade hunt to isolate the hormone erythropoietin (EPO).
Part of the story relates how Gene tried to interest traditional big pharma companies in his discovery, only to be brushed aside. Instead, Gene wound up sharing his discovery with what became Amgen. The company went on to make a windfall from recombinant production of the hormone and licensing it as a drug for patients with anemia and kidney failure. Read more »
*This blog post was originally published at ACP Internist*
We have know for some time that there are health benefits from drinking green tea. Research also shows that Omega 3 fatty acids have beneficial effects on a number of organs in the body, including the cardiovascular system, the brain, and even depression.
Dr. Fereidoon Shahidi, research professor in the Department of Biochemistry at Memorial University in Newfoundland, Canada, is hoping to show that green tea polyphenols, particularly epigallocatechin gallate (EGCG), may also prevent colon cancer and even have anti-viral effects when combined with certain Omega 3 fatty acids.
“We know from experience that green tea is not well absorbed by the body,” Dr. Shahidi said. “Our premise was to see if by adding something to it that has its own benefits, like Omega 3 fatty acids, we might get an entity that would have improved properties in terms of its absorption and health benefits,” he said. Read more »
*This blog post was originally published at EverythingHealth*